<VariationArchive VariationID="1202639" VariationName="NM_032756.4(HPDL):c.256del (p.Ala86fs)" VariationType="Deletion" Accession="VCV001202639" Version="4" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-15" DateCreated="2021-09-08" MostRecentSubmission="2022-03-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1192644" VariationID="1202639">
      <GeneList>
        <Gene Symbol="HPDL" FullName="4-hydroxyphenylpyruvate dioxygenase like" GeneID="84842" HGNC_ID="HGNC:28242" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p34.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="45326895" stop="45328710" display_start="45326895" display_stop="45328710" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="45792544" stop="45794346" display_start="45792544" display_stop="45794346" Strand="+" />
          </Location>
          <OMIM>618994</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_032756.4(HPDL):c.256del (p.Ala86fs)</Name>
      <CanonicalSPDI>NC_000001.11:45327402:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p34.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="45327403" stop="45327403" display_start="45327403" display_stop="45327403" variantLength="1" positionVCF="45327402" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="45793075" stop="45793075" display_start="45793075" display_stop="45793075" variantLength="1" positionVCF="45793074" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>A86fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.45793076del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.45793076del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.45327404del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.45327404del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008189.1" sequenceAccession="NG_008189" sequenceVersion="1" change="g.18068del">
            <Expression>NG_008189.1:g.18068del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032756.4" sequenceAccession="NM_032756" sequenceVersion="4" change="c.256del" MANESelect="true">
            <Expression>NM_032756.4:c.256del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_116145.1" sequenceAccession="NP_116145" sequenceVersion="1" change="p.Ala86fs">
            <Expression>NP_116145.1:p.Ala86fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_220" sequenceAccession="LRG_220">
            <Expression>LRG_220:g.18068del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="618994.0008" DB="OMIM" />
        <XRef Type="rs" ID="753787033" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_032756.4(HPDL):c.256del (p.Ala86fs) AND Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities" Accession="RCV001568410" Version="3">
        <ClassifiedConditionList TraitSetID="56952">
          <ClassifiedCondition DB="MedGen" ID="C5436628">Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-09-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_032756.4(HPDL):c.256del (p.Ala86fs) AND Spastic paraplegia" Accession="RCV001849530" Version="1">
        <ClassifiedConditionList TraitSetID="20865">
          <ClassifiedCondition DB="MedGen" ID="C0037772">Spastic paraplegia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-05-10" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-09-03" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2021-09-08" MostRecentSubmission="2022-03-28">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">33970200</ID>
        </Citation>
        <DescriptionHistory Dated="2022-03-23">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="20865" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32966" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Spastic paraplegia</ElementValue>
                <XRef ID="10DG0885" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                <XRef ID="HP:0001258" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0037772" DB="MedGen" />
              <XRef Type="primary" ID="HP:0001258" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007062" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007124" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007216" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="56952" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="54531" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities</ElementValue>
                <XRef ID="MONDO:0033613" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebral palsy, spastic quadriplegic, 1</ElementValue>
                <XRef ID="MONDO:0011329" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NEDSWMA</ElementValue>
                <XRef Type="MIM" ID="619026" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CPSQ1</ElementValue>
                <XRef Type="MIM" ID="619026" DB="OMIM" />
                <XRef Type="MIM" ID="603513" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10447" />
                <XRef ID="10447" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="210141" DB="Orphanet" />
              <XRef ID="641353" DB="Orphanet" />
              <XRef ID="C5436628" DB="MedGen" />
              <XRef ID="MONDO:0033613" DB="MONDO" />
              <XRef Type="MIM" ID="619026" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3521034" SubmissionDate="2021-09-03" DateLastUpdated="2021-09-08" DateCreated="2021-08-21">
        <ClinVarSubmissionID localKey="618994.0008_NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE SPASTICITY AND BRAIN WHITE MATTER ABNORMALITIES" title="HPDL, 1-BP DEL, NT256_NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE SPASTICITY AND BRAIN WHITE MATTER ABNORMALITIES" />
        <ClinVarAccession Accession="SCV001792260" DateUpdated="2021-09-08" DateCreated="2021-08-21" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-03">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 4 patients from unrelated consanguineous families, including 3 sibs from family E and 1 patient from family ZK, with neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities (NEDSWMA; 619026), Wiessner et al. (2021) identified homozygosity for a 1-bp deletion (c.256del, NM_032756.3) in the N-terminal beta-barrel domain of the HPDL gene, predicted to result in a frameshift (Ala86fs). The mutations were identified by whole-exome sequencing. The mutation had an allele frequency of 4.896 x 10(-6) in the gnomAD database and not present in the ESP and 1000 Genomes Project databases. Functional studies were not performed.</Attribute>
              <Citation>
                <ID Source="PubMed">33970200</ID>
              </Citation>
              <XRef DB="OMIM" ID="619026" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a patient (family D) with NEDSWMA, Wiessner et al. (2021) identified compound heterozygosity for 2 mutations in the HPDL gene: c.256del and a c.797C-T transition, resulting in an ile266-to-thr (I266T; 618994.0009) substitution in the C-terminal beta-barrel domain. The mutation was identified by whole-exome sequencing, and the parents were shown to be mutation carriers. The I266T mutation was reported with an allele frequency of 8.506 x 10(-6) in the gnomAD database and was not present in the ESP and 1000 Genomes Project databases. Protein levels and subcellular localization of HPDL with the I266T mutation in transfected HeLa cells were comparable to wildtype. However, Wiessner et al. (2021) tested the enzymatic function of this mutation at a homologous site (I274T) in the related HPD gene (609695) in E. coli and found that enzymatic function was reduced.</Attribute>
              <Citation>
                <ID Source="PubMed">33970200</ID>
              </Citation>
              <XRef DB="OMIM" ID="609695" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HPDL" />
          </GeneList>
          <Name>HPDL, 1-BP DEL, NT256</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, NT256</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="618994.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE SPASTICITY AND BRAIN WHITE MATTER ABNORMALITIES</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4124393" SubmissionDate="2022-03-21" DateLastUpdated="2022-03-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NM_032756.3:c.256del|HPO:0001258" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002107020" DateUpdated="2022-03-28" DateCreated="2022-03-28" Type="SCV" Version="1" SubmitterName="Yale Center for Mendelian Genomics, Yale University" OrgID="506150" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">33970200</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_032756.3:c.256del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="HP" ID="HP:0001258" />
          </Trait>
        </TraitSet>
        <StudyName>Yale Center for Mendelian Genomics</StudyName>
        <StudyDescription>The Yale Center for Mendelian Genomics is one of the national centers created by the NIH to study the genetics of rare inherited diseases.</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB11200512</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4124393" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001258" MappingRef="HP">
        <MedGen CUI="C0037772" Name="Spastic paraplegia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3521034" TraitType="Disease" MappingType="Name" MappingValue="NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE SPASTICITY AND BRAIN WHITE MATTER ABNORMALITIES" MappingRef="Preferred">
        <MedGen CUI="C5436628" Name="Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

